Skip to main content

Find Clinical Trials

Home
Conditions
Methotrexate Induced Nephrotoxicity

Clinical trial condition

Methotrexate Induced Nephrotoxicity

Explore clinical trials studying Methotrexate Induced Nephrotoxicity. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Methotrexate Induced Nephrotoxicity trial results

Not Yet Recruiting

The Possible Efficacy and Protective Effect of Empagliflozin in Rheumatoid Arthritis Patients Treated with Methotrexate

NCT06641128

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +9 more
Locations: Outpatient Clinic of Internal Medicine, Rheumatology and Immunology Department, Mansoura University Hospital Al Mansurah, Egypt

View Trial Details

Completed

Prevention of Methotrexate Induced Nephrotoxicity and Prolonged Drug Elimination Time With 12 Hours Prehydration

NCT00570817

Conditions: Ependymoma, Glioma, Hematologic Diseases, +20 more
Locations: Aarhus University Hospital, Skejby Aarhus, Aarhus N, Denmark

View Trial Details